Identification of nitric oxide as an endogenous inhibitor of 26S proteasomes in vascular endothelial cells

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Liu, Hongtao ^a   Yu, Shujie ^a   Zhang, Hua ^a   Xu, Jian ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

26S PROTEASOME; BINDING PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSAMINE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; O LINKED N ACETYLGLUCOSAMINE TRANSFERASE; PROTEASOME; PROTEIN RPT2; UNCLASSIFIED DRUG; ATP DEPENDENT 26S PROTEASE; NITRIC OXIDE;

ACYLATION; ANIMAL CELL; ARTICLE; CATALYSIS; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME MODIFICATION; GENE OVEREXPRESSION; GENE SILENCING; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR ENDOTHELIAL CELL; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; HUMAN; MALE; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 84901312447     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098486     Document Type: Article

References (86)

1. Schwartz AL, Ciechanover A (1999) The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 50: 57-74. (Pubitemid 29117052)
2. Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67: 425-479. (Pubitemid 28411135)
3. Hershko A, Ciechanover A (1992) The ubiquitin system for protein degradation. Annu Rev Biochem 61: 761-807.
4. Hershko A (1983) Ubiquitin: roles in protein modification and breakdown. Cell 34: 11-12.
5. Hershko A, Leshinsky E, Ganoth D, Heller H (1984) ATP-dependent degradation of ubiquitin-protein conjugates. Proc Natl Acad Sci U S A 81: 1619-1623. (Pubitemid 14101193)
6. Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82: 373-428. (Pubitemid 34654457)
7. Eytan E, Ganoth D, Armon T, Hershko A (1989) ATP-dependent incorporation of 20S protease into the 26S complex that degrades proteins conjugated to ubiquitin. Proc Natl Acad Sci U S A 86: 7751-7755. (Pubitemid 19265264)
8. Castro A, Bernis C, Vigneron S, Labbe JC, Lorca T (2005) The anaphase-promoting complex: a key factor in the regulation of cell cycle. Oncogene 24: 314-325. (Pubitemid 40188579)
9. Hershko A (1997) Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr Opin Cell Biol 9: 788-799.
10. Goldberg AL, Cascio P, Saric T, Rock KL (2002) The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol Immunol 39: 147-164. (Pubitemid 35013508)
11. Groettrup M, Soza A, Eggers M, Kuehn L, Dick TP, et al. (1996) A role for the proteasome regulator PA28alpha in antigen presentation. Nature 381: 166-168.
12. Orlowski RZ (1999) The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ 6: 303-313.
13. Desterro JM, Rodriguez MS, Hay RT (2000) Regulation of transcription factors by protein degradation. Cell Mol Life Sci 57: 1207-1219. (Pubitemid 30663478)
14. Fuchs SY, Fried VA, Ronai Z (1998) Stress-activated kinases regulate protein stability. Oncogene 17: 1483-1490. (Pubitemid 28458417)
15. Edwards CM, Lwin ST, Fowler JA, Oyajobi BO, Zhuang J, et al. (2009) Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo. Am J Hematol 84: 268-272.
16. Magill L, Lynas J, Morris TC, Walker B, Irvine AE (2004) Proteasome proteolytic activity in hematopoietic cells from patients with chronic myeloid leukemia and multiple myeloma. Haematologica 89: 1428-1433. (Pubitemid 39643508)
17. Bence NF, Sampat RM, Kopito RR (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292: 1552-1555. (Pubitemid 32493425)
18. Ciechanover A, Brundin P (2003) The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40: 427-446. (Pubitemid 37244106)
19. Cheroni C, Marino M, Tortarolo M, Veglianese P, De Biasi S, et al. (2009) Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis. Hum Mol Genet 18: 82-96.
20. Xu J, Wu Y, Song P, Zhang M, Wang S, et al. (2007) Proteasome-dependent degradation of guanosine 59-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 116: 944-953. (Pubitemid 47300919)
21. Whitsett J, Picklo MJ Sr, Vasquez-Vivar J (2007) 4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation. Arterioscler Thromb Vasc Biol 27: 2340-2347. (Pubitemid 350203948)
22. Queisser MA, Yao D, Geisler S, Hammes HP, Lochnit G, et al. (2010) Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes 59: 670-678.
23. Xu J, Wang S, Zhang M, Wang Q, Asfa S, et al. (2012) Tyrosine Nitration of PA700 Links Proteasome Activation to Endothelial Dysfunction in Mouse Models with Cardiovascular Risk Factors. PLoS One 7: e29649.
24. Liu H, Yu S, Xu W, Xu J (2012) Enhancement of 26S Proteasome Functionality Connects Oxidative Stress and Vascular Endothelial Inflammatory Response in Diabetes Mellitus. Arterioscler Thromb Vasc Biol 32: 2131-2140.
25. Caramori ML, Kim Y, Moore JH, Rich SS, Mychaleckyj JC, et al. (2012) Gene expression differences in skin fibroblasts in identical twins discordant for type 1 diabetes. Diabetes 61: 739-744.
26. Fu Y, Yan G, Shi L, Faustman D (1998) Antigen processing and autoimmunity. Evaluation of mRNA abundance and function of HLA-linked genes. Ann N Y Acad Sci 842: 138-155.
27. Vita JA (2011) Endothelial function. Circulation 124: e906-912.
28. Stangl K, Stangl V (2010) The ubiquitin-proteasome pathway and endothelial (dys)function. Cardiovasc Res 85: 281-290.
29. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376. (Pubitemid 11169009)
30. Noman AS, Koide N, Hassan F, I IE-K, Dagvadorj J, et al. (2009) Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production via down-regulation of MyD88 expression. Innate Immun 15: 33-41.
31. Wang WJ, Li QQ, Xu JD, Cao XX, Li HX, et al. (2008) Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells. Int J Oncol 33: 1037-1045.
32. Glockzin S, von Knethen A, Scheffner M, Brune B (1999) Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J Biol Chem 274: 19581-19586.
33. Peng ZF, Chen MJ, Yap YW, Manikandan J, Melendez AJ, et al. (2008) Proteasome inhibition: an early or late event in nitric oxide-induced neuronal death? Nitric Oxide 18: 136-145. (Pubitemid 351179424)
34. Kapadia MR, Eng JW, Jiang Q, Stoyanovsky DA, Kibbe MR (2009) Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells. Nitric Oxide 20: 279-288.
35. Shang T, Kotamraju S, Zhao H, Kalivendi SV, Hillard CJ, et al. (2005) Sepiapterin attenuates 1-methyl-4-phenylpyridinium-induced apoptosis in neuroblastoma cells transfected with neuronal NOS: role of tetrahydrobiopterin, nitric oxide, and proteasome activation. Free Radic Biol Med 39: 1059-1074. (Pubitemid 41356597)
36. Franzen R, Pfeilschifter J, Huwiler A (2002) Nitric oxide induces neutral ceramidase degradation by the ubiquitin/proteasome complex in renal mesangial cell cultures. FEBS Lett 532: 441-444. (Pubitemid 35441390)
37. Franzen R, Fabbro D, Aschrafi A, Pfeilschifter J, Huwiler A (2002) Nitric oxide induces degradation of the neutral ceramidase in rat renal mesangial cells and is counterregulated by protein kinase C. J Biol Chem 277: 46184-46190. (Pubitemid 35417609)
38. Kotamraju S, Tampo Y, Keszler A, Chitambar CR, Joseph J, et al. (2003) Nitric oxide inhibits H2O2-induced transferrin receptor-dependent apoptosis in endothelial cells: Role of ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A 100: 10653-10658. (Pubitemid 37140083)
39. Dantuma NP, Lindsten K, Glas R, Jellne M, Masucci MG (2000) Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat Biotechnol 18: 538-543. (Pubitemid 30313959)
40. Lindsten K, Menendez-Benito V, Masucci MG, Dantuma NP (2003) A transgenic mouse model of the ubiquitin/proteasome system. Nat Biotechnol 21: 897-902. (Pubitemid 36936195)
41. Lindsten K, de Vrij FM, Verhoef LG, Fischer DF, van Leeuwen FW, et al. (2002) Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation. J Cell Biol 157: 417-427. (Pubitemid 34839806)
42. Bowman AB, Yoo SY, Dantuma NP, Zoghbi HY (2005) Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum Mol Genet 14: 679-691. (Pubitemid 40309593)
43. Schmidt M, Finley D (2013) Regulation of proteasome activity in health and disease. Biochim Biophys Acta.
44. Zhang F, Su K, Yang X, Bowe DB, Paterson AJ, et al. (2003) O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115: 715-725. (Pubitemid 38030300)
45. Slawson C, Zachara NE, Vosseller K, Cheung WD, Lane MD, et al. (2005) Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J Biol Chem 280: 32944-32956. (Pubitemid 41368344)
46. Zeidan Q, Wang Z, De Maio A, Hart GW (2010) O-GlcNAc cycling enzymes associate with the translational machinery and modify core ribosomal proteins. Mol Biol Cell 21: 1922-1936.
47. Ooboshi H, Chu Y, Rios CD, Faraci FM, Davidson BL, et al. (1997) Altered vascular function after adenovirus-mediated overexpression of endothelial nitric oxide synthase. Am J Physiol 273: H265-270.
48. Heessen S, Dantuma NP, Tessarz P, Jellne M, Masucci MG (2003) Inhibition of ubiquitin/proteasome-dependent proteolysis in Saccharomyces cerevisiae by a Gly-Ala repeat. FEBS Lett 555: 397-404. (Pubitemid 37486063)
49. Fekete MR, McBride WH, Pajonk F (2005) Anthracyclines, proteasome activity and multi-drug-resistance. BMC Cancer 5: 114.
50. Zachara NE, Vosseller K, Hart GW (2011) Detection and analysis of proteins modified by O-linked N-acetylglucosamine. Curr Protoc Mol Biol Chapter 17: Unit 17 16.
51. Rex-Mathes M, Werner S, Strutas D, Griffith LS, Viebahn C, et al. (2001) O-GlcNAc expression in developing and ageing mouse brain. Biochimie 83: 583-590. (Pubitemid 32821222)
52. Xu J, Wang S, Wu Y, Song P, Zou MH (2009) Tyrosine nitration of PA700 activates the 26S proteasome to induce endothelial dysfunction in mice with angiotensin II-induced hypertension. Hypertension 54: 625-632.
53. Xu J, Xie Z, Reece R, Pimental D, Zou MH (2006) Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite. Arterioscler Thromb Vasc Biol 26: 2688-2695.
54. Schroder H (2006) No nitric oxide for HO-1 from sodium nitroprusside. Mol Pharmacol 69: 1507-1509.
55. Kim HJ, Tsoy I, Park MK, Lee YS, Lee JH, et al. (2006) Iron released by sodium nitroprusside contributes to heme oxygenase-1 induction via the cAMP-protein kinase A-mitogen-activated protein kinase pathway in RAW 264.7 cells. Mol Pharmacol 69: 1633-1640.
56. Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O (2011) Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem 80: 825-858.
57. Haltiwanger RS, Blomberg MA, Hart GW (1992) Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase. J Biol Chem 267: 9005-9013.
58. Love DC, Hanover JA (2005) The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci STKE 2005: re13.
59. Kibbe MR, Nie S, Seol DW, Kovesdi I, Lizonova A, et al. (2000) Nitric oxide prevents p21 degradation with the ubiquitin-proteasome pathway in vascular smooth muscle cells. J Vasc Surg 31: 364-374. (Pubitemid 30100045)
60. Chanvorachote P, Nimmannit U, Wang L, Stehlik C, Lu B, et al. (2005) Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory protein. J Biol Chem 280: 42044-42050. (Pubitemid 43023173)
61. Tsihlis ND, Kapadia MR, Vavra AK, Jiang Q, Fu B, et al. (2012) Nitric oxide decreases activity and levels of the 11S proteasome activator PA28 in the vasculature. Nitric Oxide 27: 50-58.
62. Tanioka T, Tamura Y, Fukaya M, Shinozaki S, Mao J, et al. (2011) Inducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic beta-cells: involvement of glycogen synthase kinase-3beta. J Biol Chem 286: 29388-29396.
63. Wells L, Vosseller K, Hart GW (2001) Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 291: 2376-2378. (Pubitemid 32231793)
64. Hanover JA (2001) Glycan-dependent signaling: O-linked N-acetylglucosamine. Faseb J 15: 1865-1876.
65. Vosseller K, Sakabe K, Wells L, Hart GW (2002) Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification. Curr Opin Chem Biol 6: 851-857. (Pubitemid 35449347)
66. Whelan SA, Hart GW (2003) Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation. Circ Res 93: 1047-1058. (Pubitemid 37485035)
67. Sumegi M, Hunyadi-Gulyas E, Medzihradszky KF, Udvardy A (2003) 26S proteasome subunits are O-linked N-acetylglucosamine-modified in Drosophila melanogaster. Biochem Biophys Res Commun 312: 1284-1289. (Pubitemid 37490956)
68. Zachara NE, Hart GW (2004) O-GlcNAc modification: a nutritional sensor that modulates proteasome function. Trends Cell Biol 14: 218-221. (Pubitemid 38591324)
69. Overath T, Kuckelkorn U, Henklein P, Strehl B, Bonar D, et al. (2012) Mapping of O-GlcNAc sites of 20 S proteasome subunits and Hsp90 by a novel biotincystamine tag. Mol Cell Proteomics 11: 467-477.
70. Jiang J, Cyr D, Babbitt RW, Sessa WC, Patterson C (2003) Chaperone-dependent regulation of endothelial nitric-oxide synthase intracellular trafficking by the co-chaperone/ubiquitin ligase CHIP. J Biol Chem 278: 49332-49341.
71. Wei Q, Xia Y (2006) Proteasome inhibition down-regulates endothelial nitricoxide synthase phosphorylation and function. J Biol Chem 281: 21652-21659. (Pubitemid 44181868)
72. Szabo C, Ischiropoulos H, Radi R (2007) Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6: 662-680. (Pubitemid 47207751)
73. Hanover JA, Krause MW, Love DC (2012) Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat Rev Mol Cell Biol 13: 312-321.
74. Rogers PA, Ding H (2001) L-cysteine-mediated destabilization of dinitrosyl iron complexes in proteins. J Biol Chem 276: 30980-30986.
75. Mannick JB, Schonhoff CM (2002) Nitrosylation: the next phosphorylation? Arch Biochem Biophys 408: 1-6. (Pubitemid 36062531)
76. Martinez-Ruiz A, Lamas S (2004) S-nitrosylation: a potential new paradigm in signal transduction. Cardiovasc Res 62: 43-52. (Pubitemid 38326810)
77. Ryu IH, Do SI (2011) Denitrosylation of S-nitrosylated OGT is triggered in LPS-stimulated innate immune response. Biochem Biophys Res Commun 408: 52-57.
78. Zhang F, Snead CM, Catravas JD (2012) Hsp90 regulates O-linked beta-N-acetylglucosamine transferase: a novel mechanism of modulation of protein O-linked beta-N-acetylglucosamine modification in endothelial cells. Am J Physiol Cell Physiol 302: C1786-1796.
79. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, et al. (1998) Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392: 821-824. (Pubitemid 28225323)
80. Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, et al. (2002) Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res 90: 866-873. (Pubitemid 34633878)
81. Balligand JL (2002) Heat shock protein 90 in endothelial nitric oxide synthase signaling: following the lead(er)? Circ Res 90: 838-841.
82. Retzlaff M, Stahl M, Eberl HC, Lagleder S, Beck J, et al. (2009) Hsp90 is regulated by a switch point in the C-terminal domain. EMBO Rep 10: 1147-1153.
83. Martinez-Ruiz A, Villanueva L, Gonzalez de Orduna C, Lopez-Ferrer D, Higueras MA, et al. (2005) S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc Natl Acad Sci U S A 102: 8525-8530. (Pubitemid 40862769)
84. Martinez-Ruiz A, Cadenas S, Lamas S (2011) Nitric oxide signaling: classical, less classical, and nonclassical mechanisms. Free Radic Biol Med 51: 17-29.
85. Butkinaree C, Park K, Hart GW (2010) O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta 1800: 96-106.
86. Xu J, Wang S, Viollet B, Zou MH (2012) Regulation of the proteasome by AMPK in endothelial cells: the role of O-GlcNAc transferase (OGT). PloS one 7: e36717.